Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?

Yilmaz, Ebru; Engin, Müge Nur; Özkan, Zeynep Gözde; Kovan, Bilal; Büyükkaya, Fikret; Poyanli, Arzu; Saglam, Sezer; Basaran, Mert; Türkmen, Cüneyt

Yilmaz, Ebru; Engin, Müge Nur; Özkan, Zeynep Gözde; Kovan, Bilal; Büyükkaya, Fikret; Poyanli, Arzu; Saglam, Sezer; Basaran, Mert; Türkmen, Cüneyt.

Afiliación

Yilmaz E; Department of Nuclear Medicine.
Engin MN; Department of Nuclear Medicine.
Özkan ZG; Department of Nuclear Medicine.
Kovan B; Department of Nuclear Medicine.
Büyükkaya F; Department of Nuclear Medicine.
Poyanli A; Department of Radiology.
Saglam S; Department of Medical Oncology, Demiroglu Bilim University, Istanbul, Turkey.
Basaran M; Department of Medical Oncology, Istanbul University, Istanbul Faculty of Medicine.
Türkmen C; Department of Nuclear Medicine.

Nucl Med Commun ; 41(12): 1242-1249, 2020 Dec.

Article en En | MEDLINE | ID: mdl-32941405

Asunto(s)

Tumores Neuroendocrinos/patología; Tumores Neuroendocrinos/radioterapia; Receptores de Somatostatina/metabolismo; Radioisótopos de Itrio/uso terapéutico; Adulto; Estudios de Cohortes; Femenino; Humanos; Neoplasias Hepáticas/radioterapia; Neoplasias Hepáticas/secundario; Masculino; Metástasis de la Neoplasia; Tumores Neuroendocrinos/metabolismo; Supervivencia sin Progresión; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Radioisótopos de Itrio / Receptores de Somatostatina / Tumores Neuroendocrinos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Nucl Med Commun Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google